Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
American Journal of Hematology|September 29, 2011
Overexpression of HOXB7 and homeobox genes characterizes multiple myeloma patients lacking the major primary immunoglobulin heavy chain locus translocationsLuca Agnelli, Paola Storti, Katia Todoerti, et al.Cancers|March 1, 2019
Loss of Stromal Galectin-1 Enhances Multiple Myeloma Development: Emphasis on a Role in OsteoclastsJoséphine Muller, Elodie Duray, Margaux Lejeune, et al.Cancers|May 28, 2020
Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering MyelomaMartina Manzoni, Valentina Marchica, Paola Storti, et al.Clinical Lymphoma, Myeloma & Leukemia|January 28, 2026
Undetectable Minimal Residual Disease in Multiple Myeloma: Bridging the Gap Between Clinical Trials and Real-life ApplicationRoberto Mina, Elisabetta Antonioli, Gregorio Barilà, et al.Journal of Hematology & Oncology|July 13, 2020
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapyValentina Marchica, Valentina Franceschi, Rosanna Vescovini, et al.Frontiers in Immunology|March 5, 2025
Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patientsVincenzo Raimondi, Paola Storti, Rosanna Vescovini, et al.Hematology Reports|May 4, 2018
Neurofibromatosis type I and multiple myeloma coexistence: A possible link?Fabrizio Accardi, Valentina Marchica, Cristina Mancini, et al.International Journal of Hematology|October 5, 2016
Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?Valentina Marchica, Fabrizio Accardi, Paola Storti, et al.Oncotarget|September 9, 2017
Lenalidomide increases human dendritic cell maturation in multiple myeloma patients targeting monocyte differentiation and modulating mesenchymal stromal cell inhibitory propertiesFederica Costa, Rosanna Vescovini, Marina Bolzoni, et al.Oncoimmunology|September 15, 2022
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral responsePaola Storti, Valentina Marchica, Rosanna Vescovini, et al.Pageof 5